Ligand Pharmaceuticals, Inc. (LGND)
213.25
-18.96
(-8.17%)
USD |
NASDAQ |
May 07, 10:59
Ligand Pharmaceuticals SG&A Expense (TTM) : 92.45M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 36.09M |
| Amicus Therapeutics, Inc. | 383.49M |
| Johnson & Johnson | 24.60B |
| ADMA Biologics, Inc. | 96.42M |
| Travere Therapeutics, Inc. | 264.36M |